| Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa GBJ Dominik Brado1#, Adetayo Emmanuel Obasa2,3#*, George Mondinde Ikomey4 ... Scientific Reports 8 (4709), 2018 | 37* | 2018 |
| Isolation and quarantine in South Africa during COVID-19: Draconian measures or proportional response? K Moodley, AE Obasa, L London SAMJ: South African Medical Journal 110 (6), 1-2, 2020 | 34 | 2020 |
| Allocation of scarce resources in Africa during COVID‐19: Utility and justice for the bottom of the pyramid? K Moodley, S Rennie, F Behets, AE Obasa, R Yemesi, L Ravez, ... Developing world bioethics 21 (1), 36-43, 2021 | 30 | 2021 |
| Structural implications of genotypic variations in HIV-1 integrase from diverse subtypes L Rogers, AE Obasa, GB Jacobs, SG Sarafianos, A Sönnerborg, U Neogi, ... Frontiers in microbiology 9, 387239, 2018 | 26 | 2018 |
| Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding R Chitongo, AE Obasa, SG Mikasi, GB Jacobs, R Cloete PLoS One 15 (5), e0223464, 2020 | 23 | 2020 |
| Drug resistance mutations against protease, reverse transcriptase and integrase inhibitors in people living with HIV-1 receiving boosted protease inhibitors in South Africa AE Obasa, SG Mikasi, D Brado, R Cloete, K Singh, U Neogi, GB Jacobs Frontiers in microbiology 11, 438, 2020 | 23 | 2020 |
| Clinical Ethics Committees in Africa: lost in the shadow of RECs/IRBs? K Moodley, SM Kabanda, L Soldaat, A Kleinsmidt, AE Obasa, S Kling BMC medical ethics 21, 1-10, 2020 | 20 | 2020 |
| What Could “Fair Allocation” during the Covid‐19 Crisis Possibly Mean in Sub‐Saharan Africa? K Moodley, L Ravez, AE Obasa, A Mwinga, W Jaoko, D Makindu, ... Hastings Center Report 50 (3), 33-35, 2020 | 19 | 2020 |
| HIV-1 integrase diversity and resistance-associated mutations and polymorphisms among integrase strand transfer inhibitor-naive HIV-1 patients from Cameroon SG Mikasi, JO Gichana, C Van der Walt, D Brado, AE Obasa, D Njenda, ... AIDS research and human retroviruses 36 (5), 450-455, 2020 | 18 | 2020 |
| Comparative strategic approaches to COVID-19 in Africa: Balancing public interest with civil liberties AE Obasa, S Singh, E Chivunze, T Burgess, F Masiye, T Mtande, ... South African medical journal= Suid-Afrikaanse tydskrif vir geneeskunde 110 …, 2020 | 17 | 2020 |
| Structural comparison of diverse Hiv-1 subtypes using molecular modelling and docking analyses of integrase inhibitors D Isaacs, SG Mikasi, AE Obasa, GM Ikomey, S Shityakov, R Cloete, ... Viruses 12 (9), 936, 2020 | 9 | 2020 |
| Ethics and governance challenges related to genomic data sharing in southern Africa: the case of SARS-CoV-2 K Moodley, N Cengiz, A Domingo, G Nair, AE Obasa, RJ Lessells, ... The Lancet Global Health 10 (12), e1855-e1859, 2022 | 7 | 2022 |
| Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South … AE Obasa, AT Ambikan, S Gupta, U Neogi, GB Jacobs BMC Infectious Diseases 21, 1-8, 2021 | 7 | 2021 |
| Responsible application of artificial intelligence in health care AE Obasa, AC Palk South African Journal of Science 119 (5-6), 1-3, 2023 | 6 | 2023 |
| COVID-19 underscores the important role of Clinical Ethics Committees in Africa K Moodley, SM Kabanda, A Kleinsmidt, AE Obasa BMC Medical Ethics 22, 1-9, 2021 | 6 | 2021 |
| Near full-length HIV-1 subtype B sequences from the early South African epidemic, detecting a BD unique recombinant form (URF) from a sample in 1985 OA Emmanuel, S Engelbrecht, GB Jacobs Scientific Reports (Nature Publisher Group) 9 (1), 2019 | 5* | 2019 |
| Preinvasive cervical lesions and high prevalence of human papilloma virus among pregnant women in Cameroon G Doh, E Mkong, GM Ikomey, AE Obasa, M Mesembe, C Fokunang, ... Germs 11 (1), 78, 2021 | 4 | 2021 |
| Multidisciplinary viral analyses in People Living with HIV-1C and receiving second-line combination antiretroviral therapy (cART) in South Africa AE Obasa Stellenbosch: Stellenbosch University, 2019 | 3 | 2019 |
| Correction: Molecular dynamic simulations to investigate the structural impact of known drug resistance mutations on HIV-1C Integrase-Dolutegravir binding R Chitongo, AE Obasa, SG Mikasi, GB Jacobs, R Cloete Plos one 15 (6), e0234581, 2020 | 2 | 2020 |
| Mutations in long terminal repeats κB transcription factor binding sites in plasma virus among south African people living with HIV-1 AE Obasa, M Ashokkumar, U Neogi, GB Jacobs AIDS Research and Human Retroviruses 35 (6), 572-576, 2019 | 2 | 2019 |
Graeme JacobsStellenbosch UniversityVerified email at sun.ac.za
